SCHEMBL22607229

SCHEMBL22607229

Cc1nnc(SCC(=O)c2ccccc2)o1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.64
HPGD P15428 6/20 0.64
TSHR P16473 3/20 0.62
ALDH1A1 P00352 6/20 0.60
POLB P06746 3/20 0.60
KMT2A Q03164 4/20 0.60
MEN1 O00255 3/20 0.60
NPC1 O15118 2/20 0.60
RAB9A P51151 2/20 0.60
USP2 O75604 1/20 0.60
HSD17B10 Q99714 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
PTPN1 P18031 1/20 0.57
LMNA P02545 2/20 0.56
MAPK1 P28482 1/20 0.56
CA12 O43570 1/20 0.55
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
CA9 Q16790 1/20 0.55
TDP1 Q9NUW8 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22607228 0.86 MAPT (0.61) MAPTHPGDTSHRALDH1A1POLB
SCHEMBL21592193 0.76 CA12 (0.69) MAPTHPGDTSHRALDH1A1POLB
SCHEMBL279942 0.75 HSD17B10 (0.49) MAPTHPGDTSHRALDH1A1POLB
SCHEMBL28214077 0.74 RAB9A (0.54) MAPTHPGDALDH1A1POLBKMT2A
SCHEMBL11522174 0.74 PKM (0.59) POLBNPC1RAB9AHSD17B10LMNA
SCHEMBL31522206 0.73 MAPT (0.67) MAPTHPGDTSHRALDH1A1POLB
SCHEMBL31522207 0.73 MAPT (0.67) MAPTHPGDTSHRALDH1A1POLB
SCHEMBL31522233 0.73 MAPT (0.88) MAPTHPGDTSHRALDH1A1POLB
SCHEMBL16157172 0.72 MAPT (0.80) MAPTHPGDTSHRALDH1A1POLB
SCHEMBL31522210 0.72 MAPT (0.88) MAPTHPGDTSHRALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11654138-B2 Therapeutic agents for treating and preventing autoimmune diseases and cancer and a screening method King Faisal University (SA) 2023-05-23 US disclosed
US-11654138-B2 Therapeutic agents for treating and preventing autoimmune diseases and cancer and a screening method King Faisal University (SA) 2023-05-23 US disclosed
WO-2022003439-A1 THERAPEUTIC AGENTS FOR TREATING AND PREVENTING AUTOIMMUNE DISEASES AND CANCER AND A SCREENING METHOD King Faisal University (SA) 2022-01-06 WO disclosed
US-20210186944-A1 THERAPEUTIC AGENTS FOR TREATING AND PREVENTING AUTOIMMUNE DISEASES AND CANCER AND A SCREENING METHOD King Faisal University (SA) 2021-06-24 US disclosed
US-20200338058-A1 THERAPEUTIC AGENTS FOR TREATING AND PREVENTING AUTOIMMUNE DISEASES AND CANCER AND A SCREENING METHOD King Faisal University (SA) 2020-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210186944-A1 THERAPEUTIC AGENTS FOR TREATING AND PREVENTING AUTOIMMUNE DISEASES AND CANCER AND A SCREENING METHOD ARID2, API5, UACA MAPT 4537/4885HPGD 3393/4885TSHR 2358/4885
US-11654138-B2 Therapeutic agents for treating and preventing autoimmune diseases and cancer and a screening method ARID2, API5, UACA MAPT 4537/4885HPGD 3393/4885TSHR 2358/4885
US-20200338058-A1 THERAPEUTIC AGENTS FOR TREATING AND PREVENTING AUTOIMMUNE DISEASES AND CANCER AND A SCREENING METHOD ARID2, API5, UACA MAPT 4537/4885HPGD 3393/4885TSHR 2358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.